Plasma Proteome Profiling for Lung Cancer Biomarker Discovery
Lung cancer is the leading cause of cancer-related deaths worldwide, yet studying the disease has remained challenging due to complex etiological factors.
In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how the research sheds new light on early-stage lung cancer diagnostics and clinical outcomes and showcase how multiomics approaches are key for characterizing complex diseases.
They’ll also highlight the extensive clinical applications of multiomics platforms in ongoing population studies for biomarker discovery.
Attend this webinar to:
- Hear how analysis of the plasma proteome identified peptide and RNA transcript biomarkers
- Gain insights into the accuracy of non-invasive multiomics approaches to lung cancer diagnostics
- Discover a multiomics platform that facilitates population-wide biomarker discovery studies
Speakers
Interested in sponsoring this webinar? Contact our friendly sales team here.
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
